Smartphone showing the adesso news feed

Press Releases

Berlin/Dortmund |

adesso ventures invests in Nia Health

adesso ventures, the venture capital arm of the adesso Group, has made an investment in the Berlin-based digital health venture Nia Health. Nia Health develops digital applications that patients can use to improve the documentation and management of chronic inflammatory skin conditions while benefiting from more personalised treatment options.

Chronic inflammatory skin conditions lower the quality of life of those affected and of their loved ones. Atopic dermatitis, also known as atopic eczema, is one of the most common chronic conditions in children and can persist into adulthood. The number and frequency of cases has increased significantly in recent decades, with roughly 10 to 15 % of children and 2.5 to 3.5 % of adults affected. The Berlin-based digital health start-up Nia Health develops digital chronic disease management solutions for skin conditions like these and supports patients throughout the treatment process. A spin-off of the university hospital Charité – Universitätsmedizin Berlin, the company develops, markets and manages leading dermatology apps. One of them is Nia, the most frequently downloaded app for people with atopic dermatitis.

To assist it in its mission, the rapidly growing company leverages modern technologies such as machine vision and natural language processing. The start-up’s main area of expertise is real-world evidence, which involves using anonymised medical information from patients’ everyday lives to help achieve major improvements in healthcare.

adesso ventures sees tremendous potential in the digital healthcare sector. Together with the lead investor, High-Tech Gründerfonds (HTGF), as well as Ventura BioMed Investors and other backers, adesso ventures is providing Nia Health with a total of EUR 3.5 million in funding. The fresh capital will be used to enhance products and finance international market expansion.

“Nia Health not only supports patients in treating their skin conditions, it also manages to generate long-term added value for medical research with the help of real-world evidence,” says Malte Unger, Managing Director at adesso ventures. “The strong team and the innovative solution from Nia Health are convincing evidence to us that medical apps for dermatology patients will have lasting success.”


Malte Unger, Managing Director at adesso ventures: ""Nia Health's strong team and innovative solution won us over for the investment.” (Copyright: adesso)

“In adesso ventures, we have found an investor that is a perfect fit for us for many reasons,” says Oliver Welter, CTO and co-founder of Nia Health. “adesso is an established player in the IT business and has comprehensive expertise in the development of digital solutions for the healthcare sector. Together, we can make our vision of better care for people with chronic skin conditions a reality.”

More information: https://www.nia-medtech.com/


Co-Founder and CTO Oliver Welter of Nia Health (right): "With adesso ventures, we have found an investor that is an ideal fit for us for many reasons." (Copyright: Nia Health)


Press service

Materials for media reports

With our press service, we provide you with various materials that complement our corporate news or serve as background information.

To the press service


Do you have any questions?

Do you have any questions about our press service or a specific request? Please contact us.

Contact

Save this page. Remove this page.